Previous 10 | Next 10 |
Image source: The Motley Fool. Inari Medical, Inc. (NASDAQ: NARI) Q1 2021 Earnings Call May 11, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Inari Medical, Inc. (NARI) Q1 2021 Earnings Call Transcript
Inari Medical, Inc. (NARI) Q1 2021 Earnings Conference Call May 11, 2021 16:30 ET Company Participants Caroline Corner - Westwicke Partners, LLC William Hoffman - President & Chief Executive Officer Mitchell Hill - Chief Financial Officer Andrew Hykes - Chief Operating Officer Thomas Tu -...
Inari Medical (NARI): Q1 GAAP EPS of $0.13 beats by $0.08.Revenue of $57.4M (+113.0% Y/Y) beats by $2.34M.COVID-19 and GuidanceDespite ongoing challenges and uncertainties in its operating environment due to the COVID-19 pandemic, Inari Medical is providing financial guidance as follows:For t...
IRVINE, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today reported financial results ...
Inari Medical (NASDAQ:NARI) is scheduled to announce Q1 earnings results on Tuesday, May 11th, after market close.The consensus EPS Estimate is $0.05 and the consensus Revenue Estimate is $55.06MOver the last 3 months, EPS estimates have seen 5 upward revisions and 0 downward. Revenue estimat...
Inari Medical has been a huge success story from the get go - its IPO nearly a year ago. I like the business a great deal and wished I paid up a bit more for this quality company at the time, which was a very different time of course. I like the business a lot, yet ever-growing va...
IRVINE, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced today that its manag...
IRVINE, Calif., April 27, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced today it will releas...
Gainers: [[GIFI]] +11.4%. [[SCOR]] +5.5%. [[AVNW]] +5.2%. [[NARI]] +4.6%. [[NTES]] +4.2%.Losers: [[CTLP]] -7.8%. [[FUTU]] -5.8%. [[ZLAB]] -5.7%. [[EVK]] -5.4%. [[CATB]] -3.3%. For further details see: GIFI, SCOR, CTLP and FUTU among after-hours movers
IRVINE, Calif., April 14, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced a new global p...
News, Short Squeeze, Breakout and More Instantly...
IRVINE, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its second quarter 2024...
Hagens Berman Encourages NARI Investors with Substantial Losses to Contact Firm Before July 12, 2024 Deadline San Francisco, California--(Newsfile Corp. - June 26, 2024) - Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses no...
2024-06-01 18:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...